database > company
CytoCore
Medical Devices & Tech
414 N. Orleans Street, Suite 502
Chicago, IL 60654 USA
phone:312.222.9550
fax:312.222.9580
Symbol CYOE
Exchange OTC
Founded 2001
Employees 4
     www.cytocoreinc.com
Research Sector Medical Devices & Tech
Summary Description
Screening systems to assist in the early detection of cancer.
Management
Robert McCullough, Jr., Chief Executive Officer and Chief Financial Officer; Richard Domanik, President and Chief Operating Officer
Ownership
Financials


* numbers in thousands
 
Keywords
cancer, cervical, cervical cancer, ovarian, breast, lung, Urology, prostate, urinary, bladder, erectile, colorectaldysplasia, diagnostic, screening, diagnostics


Comment | Printable Version | Modify profile Feb. 01, 2010

Description
CytoCore, formerly known as Molecular Diagnostics, develops cancer screening systems that can be used in a laboratory or at the point-of-care to assist in the early detection of cervical, endometrial and other cancers.
Products / Services
The InPath System is a low-cost cervical cancer screening system that may be used at the point-of-care. The system is based on the use of biomolecular markers, which identify abnormal cellular material.
Technology / Differentiation
The InPath System uses a specific combination of protein-based markers that illuminate and map abnormal cells.
Market / Customers
The market potential for cervical cancer screening represents an annual opportunity of over $3 billion dollars. The company expects initial adoption of its new paradigm in cervical cancer screening to take place outside the U.S.
Strategy
Molecular Diagnostics' seeks to establish successful markets for cervical cancer screening in the large untapped international markets where there are minimal or no screening programs in place.


2010-02-08-674